DUBLIN–(BUSINESS WIRE)–The “Breast Cancer Screening – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Breast Cancer Screening estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$22 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027.

Mammography Screening, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$16.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Breast MRI Screening segment is readjusted to a revised 7.6% CAGR for the next 7-year period.

The U. S. Market is Estimated at $3.7 Billion, While China is Forecast to Grow at 10.5% CAGR

The Breast Cancer Screening market in the U. S. is estimated at US$3.7 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 6.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Breast Ultrasound Screening Segment to Record 7.3% CAGR

In the global Breast Ultrasound Screening segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.8 Billion in the year 2020 will reach a projected size of US$2.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3 Billion by the year 2027, while Latin America will expand at a 8.6% CAGR through the analysis period.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • A&G Pharmaceutical, Inc.
  • Agendia NV
  • Biocrates Life Sciences AG
  • Hologic, Inc.
  • Metabolomic Technologies Inc.
  • Myriad Genetics, Inc.
  • Quest Diagnostics, Inc.
  • Roche Diagnostics

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Breast Cancer Screening Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for Breast Cancer Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • World Historic Review for Breast Cancer Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • World 15-Year Perspective for Breast Cancer Screening by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
  • World Current & Future Analysis for Mammography Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • World Historic Review for Mammography Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • World 15-Year Perspective for Mammography Screening by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
  • World Current & Future Analysis for Breast MRI Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • World Historic Review for Breast MRI Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • World 15-Year Perspective for Breast MRI Screening by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
  • World Current & Future Analysis for Breast Ultrasound Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
  • World Historic Review for Breast Ultrasound Screening by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
  • World 15-Year Perspective for Breast Ultrasound Screening by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/o26j83

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Written by